Summary
Citations
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.[Abstract][Full Text]
Scottish Intercollegiate Guidelines Network, Royal College of Physicians. National clinical guideline for stroke for the United Kingdom and Ireland. Apr 2023 [internet publication].[Full Text]
American College of Radiology. ACR appropriateness criteria: cerebrovascular disease. 2016 [internet publication].[Full Text]
Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.[Abstract][Full Text]
1. Förster A, Griebe M, Wolf ME, et al. How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol. 2012 Jul;259(7):1347-53.[Abstract]
2. Asan Z. Spinal concussion in adults: transient neuropraxia of spinal cord exposed to vertical forces. World Neurosurg. 2018 Jun;114:e1284-9.[Abstract][Full Text]
3. Fagre AC, Lyons S, Staples JE, et al. West nile virus and other nationally notifiable arboviral diseases - United States, 2021. MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):901-6.[Abstract][Full Text]
4. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013 May;31(2):491-510.[Abstract][Full Text]
5. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012 Feb;14(1):48-54.[Abstract][Full Text]
6. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.[Abstract][Full Text]
7. Scottish Intercollegiate Guidelines Network, Royal College of Physicians. National clinical guideline for stroke for the United Kingdom and Ireland. Apr 2023 [internet publication].[Full Text]
8. American College of Radiology. ACR appropriateness criteria: cerebrovascular disease. 2016 [internet publication].[Full Text]
9. Hacke W, Kaste M, Bluhmki E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.[Abstract][Full Text]
10. National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. April 2022 [internet publication].[Full Text]
11. Rodrigues FB, Neves JB, Caldeira D, at al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016 Apr 18;353:i1754.[Abstract][Full Text]
12. Alamowitch S, Turc G, Palaiodimou L, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. 2023 Feb;8(1):8-54.[Full Text]
13. Alamowitch S, Turc G, Palaiodimou L, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J. 2023 Mar;8(1):8-54.[Abstract][Full Text]
14. Sames TA, Storrow AB, Finkelstein JA, et al. Sensitivity of new-generation computed tomography in subarachnoid hemorrhage. Acad Emerg Med. 1996 Jan;3(1):16-20.[Abstract][Full Text]
15. Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ. 2011 Jul 18;343:d4277.[Abstract][Full Text]
16. Backes D, Rinkel GJ, Kemperman H, et al. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke. 2012 Aug;43(8):2115-9.[Abstract][Full Text]
17. Dubosh NM, Bellolio MF, Rabinstein AA, et al. Sensitivity of Early Brain Computed Tomography to Exclude Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Stroke. 2016 Mar;47(3):750-5.[Abstract][Full Text]
18. Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002277.[Abstract][Full Text]
19. Makarious D, Horwood K, Coward JIG. Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors. Eur J Cancer. 2017 Sep;82:128-36.[Abstract][Full Text]
20. Le Quintrec JS, Le Quintrec JL. Drug-induced myopathies. Baillieres Clin Rheumatol. 1991 Apr;5(1):21-38.[Abstract]
21. Dalakas MC. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):832-8.[Abstract][Full Text]
22. Amin HP, Madsen TE, Bravata DM, et al. Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association. Stroke. 2023 Mar;54(3):e109-21.[Abstract][Full Text]
23. Perez DL, Aybek S, Popkirov S, et al. A review and expert opinion on the neuropsychiatric assessment of motor functional neurological disorders. J Neuropsychiatry Clin Neurosci. 2021 Winter;33(1):14-26.[Abstract][Full Text]
24. Beca J, Sidebotham D. Chapter 37 - neurologic dysfunction. In: Andrew M, Michael G, Jerrold HL, ed(s). Cardiothoracic critical care. Philadelphia, PA: Butterworth-Heinemann;2009: 548-62.
25. Thomas KE, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis. 2002 Jul 1;35(1):46-52.[Abstract][Full Text]
26. Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov;16(11):e1.[Abstract][Full Text]
27. Mirzayan MJ, Gharabaghi A, Samii M, et al. The diagnostic value of erythrocyte sedimentation rate in management of brain tumors. Neurol Res. 2009 Jun;31(5):514-7.[Abstract]
28. Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003 Jun;31(6):1737-41.[Abstract]
29. Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections. Jan 2008 [internet publication].[Full Text]
30. Yealy DM, Fine MJ. Measurement of serum procalcitonin: a step closer to tailored care for respiratory infections? JAMA. 2009 Sep 9;302(10):1115-6.[Abstract]
31. Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3(1):45-50.[Abstract][Full Text]
32. Oomes PG, van der Meché FG, Kleyweg RP. Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré study group. Neurology. 1996 Jan;46(1):96-100.[Abstract]
33. Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol. 2006 Dec;5(12):1021-8.[Abstract]
34. Duan D, Goemans N, Takeda S, et al. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021 Feb 18;7(1):13.[Abstract][Full Text]
35. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20;362(9388):971-82.[Abstract]
36. Olson SA, Glasgow RR. Acute compartment syndrome in lower extremity musculoskeletal trauma. J Am Acad Orthop Surg. 2005 Nov;13(7):436-44.[Abstract]
37. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.[Abstract][Full Text]
38. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4.[Abstract]
39. Arendt K, Demaerschalk BM, Wingerchuk DM, et al. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20.[Abstract]
40. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204.[Abstract]
41. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.[Abstract][Full Text]
42. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.[Abstract][Full Text]
43. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.[Abstract][Full Text]
44. Venkatesan A, Geocadin RG. Diagnosis and management of acute encephalitis: a practical approach. Neurol Clin Pract. 2014 Jun;4(3):206-15.[Abstract][Full Text]
45. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol. 2010 Oct;52(10):901-7.[Abstract][Full Text]
46. National Institutes of Health. NIH stroke scale. Nov 2011 [internet publication].[Full Text]
47. Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke. 2009 Sep 9;302(10):1115-6.[Abstract][Full Text]
48. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986 Nov-Dec;17(6):1078-83.[Abstract][Full Text]
49. Fazekas F, Niederkorn K, Ebner F, et al. Relevance of neuroimaging in the evaluation of cerebral ischemia. Cerebrovasc Dis. 2009 Apr;27(suppl 1):S1-8.[Abstract]
50. Marks MP. CT in ischemic stroke. Neuroimaging Clin N Am. 1998 Aug;8(3):515-23.[Abstract]
51. Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke. 2004 Jul;35(7):1652-8.[Abstract][Full Text]
52. Gallego J, Munoz R, Martinez-Vila E. Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? Cerebrovasc Dis. 2009 Apr;27(suppl 1):S88-S96.[Abstract]
53. Schaefer PW, Romero JM, Grant PE, et al. Diffusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol. 2002 Jul;37(3):219-29.[Abstract]
54. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994 Jun 1;120(11):897-902.[Abstract]
55. Catanzaro JN, Meraj PM, Zheng S, et al. Electrocardiographic T-wave changes underlying acute cardiac and cerebral events. Am J Emerg Med. 2008 Jul;26(6):716-20.[Abstract]
56. McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):491-3.[Abstract][Full Text]
57. Clayman GL, Adams GL, Paugh DR, et al. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991 Mar;101(3):234-9.[Abstract]
58. Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope. 1998 Nov;108(11 Pt 1):1635-42.[Abstract]
59. Rosenfeld EA, Rowley AH. Infectious intracranial complications of sinusitis, other than meningitis, in children: 12-year review. Clin Infect Dis. 1994 May;18(5):750-4.[Abstract]
60. Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002 Feb;112(2):224-9.[Abstract]
61. Solomon AJ, Arrambide G, Brownlee WJ, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023 Aug;22(8):750-68.[Abstract]
62. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005 Jun;62(6):865-70.[Abstract][Full Text]
63. Winer JB. Treatment of Guillain-Barre syndrome. QJM. 2002 Nov;95(11):717-21.[Abstract][Full Text]
64. Seneviratne U. Guillain-Barre syndrome. Postgrad Med J. 2000 Dec;76(902):774-82.[Abstract][Full Text]
65. Winer JB. Guillain Barre syndrome. Mol Pathol. 2001 Dec;54(6):381-5.[Abstract][Full Text]
66. Duna G, Calabrese LH. Primary angiitis of the central nervous system. In: Kalimo H, ed. Pathology and genetics, cerebrovascular diseases. Basel, Switzerland: ISN Neuropath Press; 2005:147-51.
67. Calabrese LH. Primary angiitis of the central nervous system. In: Rheumatology. 4th ed. Hochberg M, Silman A, Smolen J, et al, eds. St. Louis, MO: Mosby; 2005.
68. Aviv RI, Benseler SM, Silverman ED, et al. MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am J Neuroradiol. 2006 Jan;27(1):192-9.[Abstract][Full Text]
69. Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981 Aug;31(8):966-71.[Abstract]
70. Murthy JM, Reddy JJ, Meena AK, et al. Acute transverse myelitis: MR characteristics. Neurol India. 1999 Dec;47(4):290-3.[Abstract][Full Text]
71. Bayas A, Gold R. Diagnostic principles in myopathies. Fortschr Neurol Psychiatr. 2003 Feb;71(2):61-6.[Abstract]
72. Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin. 1997 Aug;15(3):615-48.[Abstract]
73. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975 Feb 13;292(7):344-7.[Abstract]
74. Lehmann-Horn F, Jurkat-Rott K, Rudel R, et al. Diagnostics and therapy of muscle channelopathies: guidelines of the Ulm Muscle Center. Acta Myol. 2008 Dec;27(3):98-113.[Abstract]
75. Cherian A, Baheti NN, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008 Jan;11(1):20-7.[Full Text]
76. Khan NA, Khan AU, Hasan MI, et al. Clinical profile of periodic paralysis. Mymensingh Med J. 2012 Jan;21(1):28-33.[Abstract]
77. Dachowski LJ, DeLaney TF. Photodynamic therapy: the NCI experience and its nursing implications. Oncol Nurs Forum. 1992 Jan-Feb;19(1):63-7.[Abstract]
78. National Institute of Neurological Disorders and Stroke, NIH. Amyotrophic lateral sclerosis fact sheet. Jun 2013 [internet publication].[Full Text]
79. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994 Jul;124(suppl):96-107.[Abstract]
80. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. In: Contemporary neurology series, 49. Philadelphia, PA: F.A. Davis Company; 1998.
81. Roggenbuck J, Eubank BHF, Wright J, et al. Evidence-based consensus guidelines for ALS genetic testing and counseling. Ann Clin Transl Neurol. 2023 Nov;10(11):2074-91.[Abstract][Full Text]
82. Harrington TM, Cohen MD, Bartleson JD, et al. Elevation of creatine kinase in amyotrophic lateral sclerosis: potential confusion with polymyositis. Arthritis Rheum. 1983 Feb;26(2):201-5.[Abstract]
83. Dziewas R, Warnecke T, Schnabel M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007 Jan;22(1):63-7.[Abstract]
84. Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies 7th ed. New York, NY: McGraw-Hill Professional; 2002.
85. Potteiger JA, Carper MJ, Randall JC, et al. Changes in lower leg anterior compartment pressure before, during, and after creatine supplementation. J Athl Train. 2002 Jun;37(2):157-63.[Abstract][Full Text]
86. Owen CA, Mubarak SJ, Hargens AR, et al. Intramuscular pressures with limb compression clarification of the pathogenesis of the drug-induced muscle-compartment syndrome. N Engl J Med. 1979 May 24;300(21):1169-72.[Abstract]
87. Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003 May;16(3):123-31.[Abstract]
88. Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr. 1994 Sep;18(5):705-13.[Abstract]
89. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009 Jun;41(6):708-11.[Abstract]
90. Hersen M, Turner SM, Beidel DC, eds. Adult psychopathology and diagnosis. 5th ed. Wiley; 2007;380.
Key Articles
Referenced Articles
Sign in to access our clinical decision support tools